title: [Comprehensive organoprotection in patients with high cardiovascular risk: the possibility of ramipril from positions of evidence-based medicine].
abstract: Ramipril - a drug with a large evidence base. Various aspects of choosing a drug in cardiology from the standpoint of evidence-based medicine are risen from his example.
authors.affiliation: Research Center for Preventive Medicine, Petroverigsky per. 10, 101990 Moscow, Russia.
authors.forename: O V
authors.initials: OV
authors.lastname: Gaĭsenok
authors.forename: S Iu
authors.initials: SIu
authors.lastname: Marcevich
authors.forename: V G
authors.initials: VG
authors.lastname: Belolipetskaia
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006801:Humans; D010043:Outcome and Process Assessment, Health Care; D017257:Ramipril / Q000493:pharmacokinetics / Q000627:therapeutic use; D013810:Therapeutic Equivalency
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D017257:Ramipril